Celltrion Pharm Inc. (068760) Price & Analysis

― Followers

068760 Stock Chart & Stats

₩41900.00

-₩2,050.00(-4.66%)

Aug 18, 2026

―

Day’s Range― - ―

52-Week Range₩37,000.00 - ₩78,300.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)84.42K

Market Cap

₩1.91T

Enterprise Value₩1.85M

Total Cash (Recent Filing)₩116.93B

Total Debt (Recent Filing)₩161.31B

Price to Earnings (P/E)45.3

Beta0.33

Next Earnings

Nov 18, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)882.94

Shares Outstanding43,683,804

10 Day Avg. Volume71,840

30 Day Avg. Volume84,420

Financial Highlights & Ratios

PEG Ratio1.21

Price to Book (P/B)7.83

Price to Sales (P/S)6.37

P/FCF Ratio49.85

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

068760 FAQ

What was Celltrion Pharm Inc.’s price range in the past 12 months?

Celltrion Pharm Inc. lowest stock price was ₩37000.00 and its highest was ₩78300.00 in the past 12 months.

What is Celltrion Pharm Inc.’s market cap?

Celltrion Pharm Inc.’s market cap is ₩1.91T.

When is Celltrion Pharm Inc.’s upcoming earnings report date?

Celltrion Pharm Inc.’s upcoming earnings report date is Nov 18, 2026 which is in 90 days.

How were Celltrion Pharm Inc.’s earnings last quarter?

Celltrion Pharm Inc. released its earnings results on Aug 14, 2026. The company reported ₩310.023 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is Celltrion Pharm Inc. overvalued?

According to Wall Street analysts Celltrion Pharm Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Celltrion Pharm Inc. pay dividends?

Celltrion Pharm Inc. pays a N/A dividend of ₩200 which represents an annual dividend yield of N/A. See more information on Celltrion Pharm Inc. dividends here

What is Celltrion Pharm Inc.’s EPS estimate?

Celltrion Pharm Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Celltrion Pharm Inc. have?

Celltrion Pharm Inc. has 43,683,804 shares outstanding.

What happened to Celltrion Pharm Inc.’s price movement after its last earnings report?

Celltrion Pharm Inc. reported an EPS of ₩310.023 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.568%.

Which hedge fund is a major shareholder of Celltrion Pharm Inc.?

Currently, no hedge funds are holding shares in KR:068760

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Celltrion Pharm Inc.

Celltrion Pharm Inc. operates within South Korea's healthcare industry, primarily focusing on the production and distribution of a diverse range of pharmaceutical products. These include heptatonics, pain relievers, fever reducers, anti-inflammatory medications, allergy treatments, medications for respiratory ailments, and antibacterial agents.